IS THERE AN ASSOCIATION BETWEEN BIOCHEMICAL PARAMETERS AND PROSTATE-SPECIFIC ANTIGEN "GREY ZONE"? AN ITALIAN PILOT STUDY

被引：0
作者：
Tartaglione, S. [1 ]
Berardelli, E. [1 ]
De Vito, C. [2 ]
Nardi, A. [2 ]
Gennarini, G. [1 ]
Girelli, G. [3 ]
Angeloni, A. [4 ]
Anastasi, E. [1 ]
机构：
[1] Sapienza Univ, Dept Mol Med, Policlin Umberto 1, Rome, Italy
[2] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
[3] Sapienza Univ, Immunohematol & Transfus Med Unit, Policlin Umberto 1, Rome, Italy
[4] Sapienza Univ, Dept Expt Med, Policlin Umberto 1, Rome, Italy
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2020年 / 34卷 / 03期
关键词：
PSA; grey zone; biochemistry; lipid profile; ferritin; 25(OH)Vitamin D; VITAMIN-D; CANCER RISK; METAANALYSIS; CHOLESTEROL; BLOOD;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1179 / 1184
页数：6
相关论文
共 12 条
  • [1] Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain
    Anastasi, Emanuela
    Fuggetta, Eliana
    De Vito, Corrado
    Migliara, Giuseppe
    Viggiani, Valentina
    Manganaro, Lucia
    Granato, Teresa
    Panici, Pierluigi Benedetti
    Angeloni, Antonio
    Porpora, Maria Grazia
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (12) : E282 - E284
  • [2] Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies
    Gao, Jialin
    Wei, Wei
    Wang, Gang
    Zhou, Honglan
    Fu, Yaowen
    Liu, Nian
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 95 - 103
  • [3] The association of metabolic syndrome and its components with serum prostate-specific antigen levels
    Gao, Xiaoshuai
    Bao, Ting
    Yang, Hanwei
    Lei, Yali
    Jiang, Xianwen
    Huang, Yan
    Huang, Wenxia
    Tang, Huairong
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (01) : 36 - 41
  • [4] Vitamin D Status: Ready for Guiding Prostate Cancer Diagnosis and Treatment?
    Grant, William B.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (09) : 2241 - 2243
  • [5] Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
    Ilic, Dragan
    Djulbegovic, Mia
    Jung, Jae Hung
    Hwang, Eu Chang
    Zhou, Qi
    Cleves, Anne
    Agoritsas, Thomas
    Dahm, Philipp
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
  • [6] Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4-10 ng ml-1)
    Liu, Jun
    Wang, Zhi-Qian
    Li, Min
    Zhou, Ming-Yang
    Yu, Yi-Fei
    Zhan, Wei-Wei
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (02) : 213 - 216
  • [7] Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies
    Liu YuPeng
    Zhang YuXue
    Li PengFei
    Cheng Cheng
    Zhao YaShuang
    Li DaPeng
    Du Chen
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (07) : 1086 - 1093
  • [8] Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study
    Sawada, N.
    Inoue, M.
    Iwasaki, M.
    Yamaji, T.
    Shimazu, T.
    Sasazuki, S.
    Tsugane, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (01) : 132 - 136
  • [9] Su Q, 2017, J BUON, V22, P766
  • [10] Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries
    Tuohimaa, P
    Tenkanen, L
    Ahonen, M
    Lumme, S
    Jellum, E
    Hallmans, G
    Stattin, P
    Harvei, S
    Hakulinen, T
    Luostarinen, T
    Dillner, J
    Lehtinen, M
    Hakama, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) : 104 - 108
12